| Rainnier Dwight Mira, PA-S | |
|
3444 Masonic Dr, Alexandria, LA 71301-3615 | |
| (318) 473-9556 | |
| (318) 441-8329 |
| Full Name | Rainnier Dwight Mira |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 5 Years |
| Location | 3444 Masonic Dr, Alexandria, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346894722 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | (* (Not Available)) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Medical Center New Orleans | New orleans, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Medical Center Management Corporation | 7012150311 | 57 |
News Archive
At least for brief periods, overlapping surgery is safe for patients undergoing outpatient or "same-day" orthopedic surgery procedures, reports a study in the December 19, 2018 issue of The Journal of Bone & Joint Surgery. The journal is published in the Lippincott portfolio in partnership with Wolters Kluwer.
NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the U.S. Food and Drug Administration has approved its Investigational New Drug Application for NBTXR3, a first-in-class nanoparticle designed for direct injection into cancerous tumors, activated by stereotactic ablative radiotherapy (SABR) and administered in combination with an anti-PD1 antibody (nivolumab or pembrolizumab).
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today highlighted a further analysis of the large randomized Phase II OPUS study demonstrating an association between early tumor shrinkage and long-term median overall survival (OS) of more than 2 years for patients with KRAS wild-type metastatic colorectal cancer (mCRC) treated with Erbitux® (cetuximab) plus FOLFOX standard chemotherapy.
Even as Republicans unveiled their 2012 budget plan, negotiations continued and stalled on Capitol Hill, as lawmakers attempt to reach an agreement on current-year spending to avert a government shutdown on Friday.
Alexion Pharmaceuticals, Inc. today announced that the Company's study of eculizumab in a small group of 14 patients with severe and refractory generalized myasthenia gravis, an ultra-rare and debilitating form of generalized myasthenia gravis (gMG), showed a strong disease improvement signal.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rainnier Dwight Mira, PA-S 3444 Masonic Dr, Alexandria, LA 71301-3615 Ph: (318) 473-9556 | Rainnier Dwight Mira, PA-S 3444 Masonic Dr, Alexandria, LA 71301-3615 Ph: (318) 473-9556 |
News Archive
At least for brief periods, overlapping surgery is safe for patients undergoing outpatient or "same-day" orthopedic surgery procedures, reports a study in the December 19, 2018 issue of The Journal of Bone & Joint Surgery. The journal is published in the Lippincott portfolio in partnership with Wolters Kluwer.
NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the U.S. Food and Drug Administration has approved its Investigational New Drug Application for NBTXR3, a first-in-class nanoparticle designed for direct injection into cancerous tumors, activated by stereotactic ablative radiotherapy (SABR) and administered in combination with an anti-PD1 antibody (nivolumab or pembrolizumab).
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today highlighted a further analysis of the large randomized Phase II OPUS study demonstrating an association between early tumor shrinkage and long-term median overall survival (OS) of more than 2 years for patients with KRAS wild-type metastatic colorectal cancer (mCRC) treated with Erbitux® (cetuximab) plus FOLFOX standard chemotherapy.
Even as Republicans unveiled their 2012 budget plan, negotiations continued and stalled on Capitol Hill, as lawmakers attempt to reach an agreement on current-year spending to avert a government shutdown on Friday.
Alexion Pharmaceuticals, Inc. today announced that the Company's study of eculizumab in a small group of 14 patients with severe and refractory generalized myasthenia gravis, an ultra-rare and debilitating form of generalized myasthenia gravis (gMG), showed a strong disease improvement signal.
› Verified 3 days ago
Dustin Rand Goudeau, PAC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3351 Masonic Dr, Alexandria, LA 71301 Phone: 318-473-9556 Fax: 318-441-8339 | |
Chrishonda Marie Whitlock, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 3330 Masonic Dr, Alexandria, LA 71301 Phone: 318-487-1122 | |
Ms. Kelly G White, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 605b Medical Center Dr, Alexandria, LA 71301 Phone: 318-442-2232 Fax: 318-442-2192 | |
Elizabeth Kathleen Robichaux, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 221 Windermere Blvd, Alexandria, LA 71303 Phone: 318-443-9773 Fax: 318-443-9799 | |
Savanah Booker, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 3601 Jackson St, Alexandria, LA 71303 Phone: 318-787-6877 | |
Mr. Charles M Johnson Jr., PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3444 Masonic Drive, Alexandria, LA 71301 Phone: 318-473-9556 Fax: 318-441-8310 | |
Kevin James Murphy, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3704 North Blvd, Suite C, Alexandria, LA 71301 Phone: 318-443-4576 Fax: 318-449-5579 |